Analyst Ratings for Regeneron Pharma (regn)

regn Rating Summary

regn Price Target Summary

* Over Last 12-Mos
  |   Expand Research on regn
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $495.77 (+23.3%) * Over Last 12-Mos
Rating Score: 5 / 10   Percentile Rank: 55%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
8/5/2016 Baird
» Updated 9/21/2016
Downgrade Neutral
(Outperform)
448.00
(N/A)
433.40 402.02 -7.24% Details
6/29/2016 Bernstein New Coverage Outperform
(N/A)
400.00
(N/A)
339.78 402.02 18.32% Details
Like REGN Ratings? Also take a look at SNY, SAN, AMGN, CELG

REGN Ratings News